Consistently, somatic mutations and decreased copy number of SMARCA4 predicted a tendency towards the favourable outcome of melanoma patients (Figure S4), indicating SMARCA4 was involved in the proliferation of melanoma. Here, SMARCA4 is linked to melanoma.